Literature DB >> 25448085

Evaluation of the cytotoxic and mutagenic potential of three ginkgolic acids.

Kerstin Berg1, Christine Braun1, Isabel Krug1, Dieter Schrenk2.   

Abstract

Ginkgolic acids (GAs) are alkylphenols which can be found in the fruits and leaves of Ginkgo biloba L. (Ginkgoaceae) used in herbal teas, drugs and food supplements. Standardized leaf extracts of G. biloba are widely used in the therapy of cognitive decline including Alzheimer's diseases. However, GAs are known to have cytotoxic and allergenic potential and are suspected to possess genotoxic properties. Therefore, we examined in this study the cytotoxicity and mutagenicity of three major GAs with different alkyl or alkenyl groups (13:0, 15:1, 17:1). Cytotoxicity was assessed in male Chinese hamster lung fibroblasts (V79 cells) using the resazurin reduction assay. The substances showed concentration dependent cytotoxic effects after 24h of incubation at concentrations of 50μM and higher. Mutagenicity was determined by using the Ames fluctuation assay in different Salmonella typhimurium strains (TA97a, TA98, TA100 and TA102) with and without exogenous metabolic activation (S9 mix). Furthermore, we analyzed the mutagenic potency of the three major GAs in V79 cells by performing the hypoxanthine phosphoribosyl transferase (HPRT) assay which detects gene mutations at the HPRT locus. None of the mutagenic assays showed any increase in mutagenicity above background. Therefore, these data provide evidence that the GAs tested have some cytotoxic potency but are not mutagenic. Thus, our findings contribute to the risk assessment of preparations containing plant extracts from G. biloba.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ames’ test; Cytotoxicity; Ginkgobiloba; Ginkgolic acids; HPRT assay; Mutagenicity

Mesh:

Substances:

Year:  2014        PMID: 25448085     DOI: 10.1016/j.tox.2014.10.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51.

Authors:  Eun Ju Lee; Injoo Hwang; Ji Yeon Lee; Jong Nam Park; Keun Cheon Kim; Gi-Hwan Kim; Chang-Mo Kang; Irene Kim; Seo-Yeon Lee; Hyo-Soo Kim
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

2.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

3.  Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro, Una, and Zika Viruses.

Authors:  Dalkiria Campos; Susana Navarro; Yessica Yadira Llamas-González; Madelaine Sugasti; José González-Santamaría
Journal:  Viruses       Date:  2020-04-15       Impact factor: 5.048

4.  Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.

Authors:  Gretchen L Bentz; Angela J Lowrey; Dustin C Horne; Vy Nguyen; Austin R Satterfield; Tabithia D Ross; Abigail E Harrod; Olga N Uchakina; Robert J McKallip
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

5.  Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.

Authors:  Maimoona S Bhutta; Oren Shechter; Elisa S Gallo; Stephen D Martin; Esther Jones; Gustavo F Doncel; Ronen Borenstein
Journal:  Viruses       Date:  2021-01-09       Impact factor: 5.048

6.  Validation of a 16th Century Traditional Chinese Medicine Use of Ginkgo biloba as a Topical Antimicrobial.

Authors:  François Chassagne; Xinyi Huang; James T Lyles; Cassandra L Quave
Journal:  Front Microbiol       Date:  2019-04-16       Impact factor: 5.640

7.  Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells.

Authors:  Lukas Rutz; Lan Gao; Jan-Heiner Küpper; Dieter Schrenk
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.